Page last updated: 2024-09-03

5-fluoro-2,2'-cyclocytidine and ancitabine

5-fluoro-2,2'-cyclocytidine has been researched along with ancitabine in 5 studies

Compound Research Comparison

Studies
(5-fluoro-2,2'-cyclocytidine)
Trials
(5-fluoro-2,2'-cyclocytidine)
Recent Studies (post-2010)
(5-fluoro-2,2'-cyclocytidine)
Studies
(ancitabine)
Trials
(ancitabine)
Recent Studies (post-2010) (ancitabine)
5101181013

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M1
Meyers, PA; Redner, A; Steinherz, PG; Tan, CT1
du Plessis, HE; Falkson, G; Falkson, HC; Meyer, TE1
Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L1
Floersheim, GL; Torhorst, J1

Trials

1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and ancitabine

ArticleYear
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
    Cancer, 1981, Nov-15, Volume: 48, Issue:10

    Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine

1981

Other Studies

4 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and ancitabine

ArticleYear
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Cancer clinical trials, 1978,Winter, Volume: 1, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous

1978
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Cancer, 1989, Dec-15, Volume: 64, Issue:12

    Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male

1989
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
    Cancer clinical trials, 1980, Volume: 3, Issue:4

    Topics: Ancitabine; Antineoplastic Agents; Cytarabine; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Leukopenia; Male; Nausea; Vomiting

1980
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
    Oncology, 1981, Volume: 38, Issue:6

    Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer Cells, Natural; Leukemia, Experimental; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Moloney murine leukemia virus; Neoplasms, Experimental; Sarcoma, Experimental

1981